Commonwealth Retirement Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
FIA
ACA
MSCM
ACM
IWS
Commonwealth Retirement Investments's IHE Position: Q1 2026 in Review
Commonwealth Retirement Investments reduced its iShares US Pharmaceuticals ETF (IHE) stake by 46% in Q1 2026, selling an estimated $250K and leaving 3,290 shares worth $285K. The position accounts for 0.09% of the portfolio, ranked #111.
Commonwealth Retirement Investments first reported a position in IHE in Q4 2024 and has held it in 3 quarters since. The position peaked at $536K in Q4 2024. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.
- Commonwealth Retirement Investments held 3,290 shares of iShares US Pharmaceuticals ETF worth $285K as of Q1 2026.
- Commonwealth Retirement Investments sold 2,856 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $250K.
- iShares US Pharmaceuticals ETF made up 0.09% of Commonwealth Retirement Investments's portfolio in Q1 2026, its #111 holding.
- Commonwealth Retirement Investments first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and has held it in 3 quarters since.
- Commonwealth Retirement Investments's iShares US Pharmaceuticals ETF position peaked at $536K in Q4 2024.
- 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.
Based on Commonwealth Retirement Investments's 13F filing for Q1 2026, filed 11 May 2026.